Adamcapital Gestao De Recursos Ltda. Regeneron Pharmaceuticals, Inc. Transaction History

Adamcapital Gestao De Recursos Ltda.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$372.08 - $439.57 $36.4 Million - $43 Million	-97,753 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$335.82 - $403.04 $3.58 Million - $4.3 Million	10,673 Added 12.26%	97,753 $36.5 Million
Q3 2018 Oct 22, 2018	SELL	$351.14 - $408.51 $6.85 Million - $7.96 Million	-19,495 Reduced 18.29%	87,080 $35.2 Million
Q2 2018 Jul 19, 2018	SELL	$284.6 - $344.99 $12.4 Million - $15 Million	-43,550 Reduced 29.01%	106,575 $36.8 Million
Q1 2018 Apr 13, 2018	BUY	$315.82 - $393.78 $22.8 Million - $28.5 Million	72,320 Added 92.95%	150,125 $51.7 Million
Q4 2017 Feb 22, 2018	BUY	$358.63 - $469.95 $27.9 Million - $36.6 Million	77,805	77,805 $29.3 Million

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Adamcapital Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Adamcapital Gestao De Recursos Ltda. with notifications on news.